Advertisement
Screener

PACIRA BIOSCIENCES, INC. (PCRX) Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent

2.0 / 5 stars · 29/74 Roast Me

PACIRA BIOSCIENCES, INC. Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent

PACIRA BIOSCIENCES, INC. (PCRX) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent of -$214.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.

Financial Statements › Income Statement › Unrealized Gains

us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent · last filed 2026-08-04

  • PACIRA BIOSCIENCES, INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-06-30 was -$214.00K, a 107.89% decline year-over-year.
  • PACIRA BIOSCIENCES, INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-03-31 was -$872.00K, a 186.51% decline year-over-year.
  • PACIRA BIOSCIENCES, INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-12-31 was $204.00K.
  • PACIRA BIOSCIENCES, INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-09-30 was $61.00K, a 89.35% decline year-over-year.
  • PACIRA BIOSCIENCES, INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2025 was $3.98M, a 4050.00% increase from fiscal 2024.
  • PACIRA BIOSCIENCES, INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2024 was $96.00K, a 84.69% decline from fiscal 2023.
  • PACIRA BIOSCIENCES, INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2023 was $627.00K.
  • PACIRA BIOSCIENCES, INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2022 was -$547.00K.
Period endOther Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 monthOther Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month as first filedOther Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 monthOther Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 9 monthOther Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month
2026-06-30-$214.00K
10-Q · filed 2026-08-04
-$1.09M
10-Q · filed 2026-08-04
-$882.00K
derived: sum of 3 quarters · filed 2026-08-04
-$821.00K
derived: sum of 4 quarters · filed 2026-08-04
2026-03-31-$872.00K
10-Q · filed 2026-04-30
-$668.00K
derived: sum of 2 quarters · filed 2026-04-30
-$607.00K
derived: sum of 3 quarters · filed 2026-04-30
$2.10M
derived: sum of 4 quarters · filed 2026-08-04
2025-12-31$204.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$265.00K
derived: sum of 2 quarters · filed 2026-02-26
$2.98M
derived: sum of 3 quarters · filed 2026-08-04
$3.98M
10-K · filed 2026-02-26
2025-09-30$61.00K
10-Q · filed 2025-11-06
$2.77M
derived: sum of 2 quarters · filed 2026-08-04
$3.78M
10-Q · filed 2025-11-06
$3.44M
derived: sum of 4 quarters · filed 2026-08-04
2025-06-30$2.71M
10-Q · filed 2026-08-04
$3.72M
10-Q · filed 2026-08-04
$3.38M
derived: sum of 3 quarters · filed 2026-08-04
$3.96M
derived: sum of 4 quarters · filed 2026-08-04
2025-03-31$1.01M
10-Q · filed 2026-04-30
$673.00K
derived: sum of 2 quarters · filed 2026-04-30
$1.25M
derived: sum of 3 quarters · filed 2026-04-30
$1.20M
derived: sum of 4 quarters · filed 2026-04-30
2024-12-31-$335.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$238.00K
derived: sum of 2 quarters · filed 2026-02-26
$191.00K
derived: sum of 3 quarters · filed 2026-02-26
$96.00K
10-K · filed 2026-02-26
2024-09-30$573.00K
10-Q · filed 2025-11-06
$526.00K
derived: sum of 2 quarters · filed 2025-11-06
$431.00K
10-Q · filed 2025-11-06
$688.00K
derived: sum of 4 quarters · filed 2026-02-26
2024-06-30-$47.00K
10-Q · filed 2025-08-05
-$142.00K
10-Q · filed 2025-08-05
$115.00K
derived: sum of 3 quarters · filed 2026-02-26
$278.00K
derived: sum of 4 quarters · filed 2026-02-26
2024-03-31-$95.00K
10-Q · filed 2025-05-08
$162.00K
derived: sum of 2 quarters · filed 2026-02-26
$325.00K
derived: sum of 3 quarters · filed 2026-02-26
$289.00K
derived: sum of 4 quarters · filed 2026-02-26
2023-12-31$257.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$420.00K
derived: sum of 2 quarters · filed 2026-02-26
$384.00K
derived: sum of 3 quarters · filed 2026-02-26
$627.00K
10-K · filed 2026-02-26
2023-09-30$163.00K
10-Q · filed 2024-11-06
$127.00K
derived: sum of 2 quarters · filed 2024-11-06
$370.00K
10-Q · filed 2024-11-06
$660.00K
derived: sum of 4 quarters · filed 2025-02-27
2023-06-30-$36.00K
10-Q · filed 2024-07-30
$207.00K
10-Q · filed 2024-07-30
$497.00K
derived: sum of 3 quarters · filed 2025-02-27
$432.00K
derived: sum of 4 quarters · filed 2025-02-27
2023-03-31$243.00K
10-Q · filed 2024-05-07
$533.00K
derived: sum of 2 quarters · filed 2025-02-27
$468.00K
derived: sum of 3 quarters · filed 2025-02-27
$390.00K
derived: sum of 4 quarters · filed 2025-02-27
2022-12-31$290.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27
$225.00K
derived: sum of 2 quarters · filed 2025-02-27
$147.00K
derived: sum of 3 quarters · filed 2025-02-27
-$547.00K
10-K · filed 2025-02-27
2022-09-30-$65.00K
10-Q · filed 2023-11-02
-$143.00K
derived: sum of 2 quarters · filed 2023-11-02
-$837.00K
10-Q · filed 2023-11-02
-$823.00K
derived: sum of 4 quarters · filed 2024-02-29
2022-06-30-$78.00K
10-Q · filed 2023-08-02
-$772.00K
10-Q · filed 2023-08-02
-$758.00K
derived: sum of 3 quarters · filed 2024-02-29
-$786.00K
derived: sum of 4 quarters · filed 2024-02-29
2022-03-31-$694.00K
10-Q · filed 2023-05-03
-$680.00K
derived: sum of 2 quarters · filed 2024-02-29
-$708.00K
derived: sum of 3 quarters · filed 2024-02-29
-$699.00K
derived: sum of 4 quarters · filed 2024-02-29
2021-12-31$14.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29
-$14.00K
derived: sum of 2 quarters · filed 2024-02-29
-$5.00K
derived: sum of 3 quarters · filed 2024-02-29
-$151.00K
10-K · filed 2024-02-29
2021-09-30-$28.00K
10-Q · filed 2022-11-03
-$19.00K
derived: sum of 2 quarters · filed 2022-11-03
-$165.00K
10-Q · filed 2022-11-03
-$694.00K
derived: sum of 4 quarters · filed 2023-02-28
2021-06-30$9.00K
10-Q · filed 2022-08-03
-$137.00K
10-Q · filed 2022-08-03
-$666.00K
derived: sum of 3 quarters · filed 2023-02-28
-$1.31M
derived: sum of 4 quarters · filed 2023-02-28
2021-03-31-$146.00K
10-Q · filed 2022-05-04
-$675.00K
derived: sum of 2 quarters · filed 2023-02-28
-$1.32M
derived: sum of 3 quarters · filed 2023-02-28
$1.22M
derived: sum of 4 quarters · filed 2023-02-28
2020-12-31-$529.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28
-$1.17M
derived: sum of 2 quarters · filed 2023-02-28
$1.36M
derived: sum of 3 quarters · filed 2023-02-28
-$4.00K
10-K · filed 2023-02-28
2020-09-30-$643.00K
10-Q · filed 2021-11-03
$1.89M
derived: sum of 2 quarters · filed 2021-11-03
$525.00K
10-Q · filed 2021-11-03
$400.00K
derived: sum of 4 quarters · filed 2022-02-28
2020-06-30$2.54M
10-Q · filed 2021-08-03
$1.17M
10-Q · filed 2021-08-03
$1.04M
derived: sum of 3 quarters · filed 2022-02-28
$990.00K
derived: sum of 4 quarters · filed 2022-02-28
2020-03-31-$1.37M
10-Q · filed 2021-05-04
-$1.49M
derived: sum of 2 quarters · filed 2022-02-28
-$1.55M
derived: sum of 3 quarters · filed 2022-02-28
-$1.23M
derived: sum of 4 quarters · filed 2022-02-28
2019-12-31-$125.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28
-$178.00K
derived: sum of 2 quarters · filed 2022-02-28
$140.00K
derived: sum of 3 quarters · filed 2022-02-28
$602.00K
10-K · filed 2022-02-28
2019-09-30-$53.00K
10-Q · filed 2020-10-30
$265.00K
derived: sum of 2 quarters · filed 2020-10-30
$727.00K
10-Q · filed 2020-10-30
$688.00K
derived: sum of 4 quarters · filed 2021-03-01
2019-06-30$318.00K
10-Q · filed 2020-08-06
$780.00K
10-Q · filed 2020-08-06
$741.00K
derived: sum of 3 quarters · filed 2021-03-01
$1.04M
derived: sum of 4 quarters · filed 2021-03-01
2019-03-31$462.00K
10-Q · filed 2020-05-07
$423.00K
derived: sum of 2 quarters · filed 2021-03-01
$727.00K
derived: sum of 3 quarters · filed 2021-03-01
$1.08M
derived: sum of 4 quarters · filed 2021-03-01
2018-12-31-$39.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01
$265.00K
derived: sum of 2 quarters · filed 2021-03-01
$621.00K
derived: sum of 3 quarters · filed 2021-03-01
$174.00K
10-K · filed 2021-03-01
2018-09-30$304.00K
10-Q · filed 2019-11-08
$305.00K
10-Q · filed 2018-11-01
$660.00K
derived: sum of 2 quarters · filed 2019-11-08
$213.00K
10-Q · filed 2019-11-08
-$174.00K
derived: sum of 4 quarters · filed 2020-02-21
2018-06-30$356.00K
10-Q · filed 2019-08-08
-$91.00K
10-Q · filed 2019-08-08
-$478.00K
derived: sum of 3 quarters · filed 2020-02-21
-$481.00K
derived: sum of 4 quarters · filed 2020-02-21
2018-03-31-$447.00K
10-Q · filed 2019-05-02
-$834.00K
derived: sum of 2 quarters · filed 2020-02-21
-$837.00K
derived: sum of 3 quarters · filed 2020-02-21
-$819.00K
derived: sum of 4 quarters · filed 2020-02-21
2017-12-31-$387.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21
-$390.00K
derived: sum of 2 quarters · filed 2020-02-21
-$372.00K
derived: sum of 3 quarters · filed 2020-02-21
-$424.00K
10-K · filed 2020-02-21
2017-09-30-$3.00K
10-Q · filed 2018-11-01
$15.00K
derived: sum of 2 quarters · filed 2018-11-01
-$37.00K
10-Q · filed 2018-11-01
-$39.00K
derived: sum of 4 quarters · filed 2019-02-28
2017-06-30$18.00K
10-Q · filed 2018-08-02
-$34.00K
10-Q · filed 2018-08-02
-$36.00K
derived: sum of 3 quarters · filed 2019-02-28
-$202.00K
derived: sum of 4 quarters · filed 2019-02-28
2017-03-31-$52.00K
10-Q · filed 2018-05-03
-$54.00K
derived: sum of 2 quarters · filed 2019-02-28
-$220.00K
derived: sum of 3 quarters · filed 2019-02-28
-$131.00K
derived: sum of 4 quarters · filed 2019-02-28
2016-12-31-$2.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28
-$168.00K
derived: sum of 2 quarters · filed 2019-02-28
-$79.00K
derived: sum of 3 quarters · filed 2019-02-28
$22.00K
10-K · filed 2019-02-28
2016-09-30-$166.00K
10-Q · filed 2017-11-08
-$77.00K
derived: sum of 2 quarters · filed 2017-11-08
$24.00K
10-Q · filed 2017-11-08
$1.00K
derived: sum of 4 quarters · filed 2018-02-28
2016-06-30$89.00K
10-Q · filed 2017-08-02
$190.00K
10-Q · filed 2017-08-02
$167.00K
derived: sum of 3 quarters · filed 2018-02-28
$165.00K
derived: sum of 4 quarters · filed 2018-02-28
2016-03-31$101.00K
10-Q · filed 2017-05-04
$78.00K
derived: sum of 2 quarters · filed 2018-02-28
$76.00K
derived: sum of 3 quarters · filed 2018-02-28
$77.00K
derived: sum of 4 quarters · filed 2018-02-28
2015-12-31-$23.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28
-$25.00K
derived: sum of 2 quarters · filed 2018-02-28
-$24.00K
derived: sum of 3 quarters · filed 2018-02-28
$28.00K
10-K · filed 2018-02-28
2015-09-30-$2.00K
10-Q · filed 2016-11-02
-$1.00K
derived: sum of 2 quarters · filed 2016-11-02
$51.00K
10-Q · filed 2016-11-02
-$34.00K
derived: sum of 4 quarters · filed 2017-03-01
2015-06-30$1.00K
10-Q · filed 2016-08-04
$53.00K
10-Q · filed 2016-08-04
-$32.00K
derived: sum of 3 quarters · filed 2017-03-01
$7.00K
derived: sum of 4 quarters · filed 2017-03-01
2015-03-31$52.00K
10-Q · filed 2016-05-02
-$33.00K
derived: sum of 2 quarters · filed 2017-03-01
$6.00K
derived: sum of 3 quarters · filed 2017-03-01
-$30.00K
derived: sum of 4 quarters · filed 2017-03-01
2014-12-31-$85.00K
10-K · filed 2017-03-01
-$46.00K
derived: sum of 2 quarters · filed 2017-03-01
-$82.00K
derived: sum of 3 quarters · filed 2017-03-01
-$85.00K
10-K · filed 2016-02-25
2014-09-30$39.00K
10-Q · filed 2015-10-27
$3.00K
derived: sum of 2 quarters · filed 2015-10-27
$3.00K
10-Q · filed 2015-10-27
-$9.00K
derived: sum of 4 quarters · filed 2016-02-25
2014-06-30-$36.00K
10-Q · filed 2015-07-30
-$36.00K
10-Q · filed 2015-07-30
-$48.00K
derived: sum of 3 quarters · filed 2016-02-25
-$45.00K
derived: sum of 4 quarters · filed 2016-02-25
2014-03-31$0.00
10-Q · filed 2015-04-30
-$12.00K
derived: sum of 2 quarters · filed 2016-02-25
-$9.00K
derived: sum of 3 quarters · filed 2016-02-25
-$40.00K
derived: sum of 4 quarters · filed 2016-02-25
2013-12-31-$12.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25
-$9.00K
derived: sum of 2 quarters · filed 2016-02-25
-$40.00K
derived: sum of 3 quarters · filed 2016-02-25
-$22.00K
10-K · filed 2016-02-25
2013-09-30$3.00K
10-Q · filed 2014-10-30
-$28.00K
derived: sum of 2 quarters · filed 2014-10-30
-$10.00K
10-Q · filed 2014-10-30
-$48.00K
derived: sum of 4 quarters · filed 2015-02-24
2013-06-30-$31.00K
10-Q · filed 2014-07-31
-$14.00K
10-Q · filed 2014-07-31
-$51.00K
derived: sum of 3 quarters · filed 2015-02-24
-$85.00K
derived: sum of 4 quarters · filed 2015-02-24
2013-03-31$17.00K
10-Q · filed 2014-05-01
-$20.00K
derived: sum of 2 quarters · filed 2015-02-24
-$54.00K
derived: sum of 3 quarters · filed 2015-02-24
$27.00K
derived: sum of 4 quarters · filed 2015-02-24
2012-12-31-$37.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24
-$71.00K
derived: sum of 2 quarters · filed 2015-02-24
$10.00K
derived: sum of 3 quarters · filed 2015-02-24
$12.00K
10-K · filed 2015-02-24
2012-09-30-$34.00K
10-Q · filed 2013-10-31
$47.00K
derived: sum of 2 quarters · filed 2013-10-31
$49.00K
10-Q · filed 2013-10-31
$69.00K
derived: sum of 4 quarters · filed 2014-02-25
2012-06-30$81.00K
10-Q · filed 2013-08-06
$83.00K
10-Q · filed 2013-08-06
$103.00K
derived: sum of 3 quarters · filed 2014-02-25
$98.00K
derived: sum of 4 quarters · filed 2014-02-25
2012-03-31$2.00K
10-Q · filed 2013-05-08
$22.00K
derived: sum of 2 quarters · filed 2014-02-25
$17.00K
derived: sum of 3 quarters · filed 2014-02-25
2011-12-31$20.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25
$15.00K
derived: sum of 2 quarters · filed 2014-02-25
$15.00K
10-K · filed 2014-02-25
2011-09-30-$5.00K
10-Q · filed 2012-11-01
-$5.00K
10-Q · filed 2012-11-01

Similar stocks

Stock NameCountryMarket CapPE Ratio
Janux Therapeutics, Inc. (JANX)United States$1.019B-9.15
MoonLake Immunotherapeutics (MLTX)Switzerland$1.031B-5.43
Savara Inc (SVRA)United States$1.044B-9.10
Corvus Pharmaceuticals, Inc. (CRVS)United States$0.994B-23.25
MANNKIND CORP (MNKD)United States$1.058B-30.41
Alto Neuroscience, Inc. (ANRO)United States$1.065B-11.02
Kura Oncology, Inc. (KURA)United States$0.967B-3.29
Arbutus Biopharma Corp (ABUS)$0.965B6.19
Jade Biosciences, Inc. (JBIO)United States$0.936B-9.21
Amphastar Pharmaceuticals, Inc. (AMPH)United States$1.116B10.93